<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34440163</PMID><DateRevised><Year>2021</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>05</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>COVID-19 Disease, Women's Predominant Non-Heparin Vaccine-Induced Thrombotic Thrombocytopenia and Kounis Syndrome: A Passepartout Cytokine Storm Interplay.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">959</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines9080959</ELocationID><Abstract><AbstractText Label="UNLABELLED">Coronavirus disease 2019 (COVID-19) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) constitute one of the deadliest pandemics in modern history demonstrating cardiovascular, gastrointestinal, hematologic, mucocutaneous, respiratory, neurological, renal and testicular manifestations and further complications. COVID-19-induced excessive immune response accompanied with uncontrolled release of cytokines culminating in cytokine storm seem to be the common pathogenetic mechanism of these complications. The aim of this narrative review is to elucidate the relation between anaphylaxis associated with profound hypotension or hypoxemia with pro-inflammatory cytokine release. COVID-19 relation with Kounis syndrome and post-COVID-19 vaccination correlation with heparin-induced thrombocytopenia with thrombosis (HITT), especially serious cerebral venous sinus thrombosis, were also reviewed.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A current literature search in PubMed, Embase and Google databases was performed to reveal the pathophysiology, prevalence, clinical manifestation, correlation and treatment of COVID-19, anaphylaxis with profuse hypotension, Kounis acute coronary syndrome and thrombotic events post vaccination.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The same key immunological pathophysiology mechanisms and cells seem to underlie COVID-19 cardiovascular complications and the anaphylaxis-associated Kounis syndrome. The myocardial injury in patients with COVID-19 has been attributed to coronary spasm, plaque rupture and microthrombi formation, hypoxic injury or cytokine storm disposing the same pathophysiology with the three clinical variants of Kounis syndrome. COVID-19-interrelated vaccine excipients as polysorbate, polyethelene glycol (PEG) and trometamol constitute potential allergenic substances.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Better acknowledgement of the pathophysiological mechanisms, clinical similarities, multiorgan complications of COVID-19 or other viral infections as dengue and human immunodeficiency viruses along with the action of inflammatory cells inducing the Kounis syndrome could identify better immunological approaches for prevention, treatment of the COVID-19 pandemic as well as post-COVID-19 vaccine adverse reactions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kounis</LastName><ForeName>Nicholas G</ForeName><Initials>NG</Initials><Identifier Source="ORCID">0000-0002-9751-6710</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, University of Patras Medical School, 26221 Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koniari</LastName><ForeName>Ioanna</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Hospital of South Manchester NHS Foundation Trust, Manchester M23 9LT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Gregorio</LastName><ForeName>Cesare</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3022-266X</Identifier><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, University of Messina Medical School, 98122 Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assimakopoulos</LastName><ForeName>Stelios F</ForeName><Initials>SF</Initials><Identifier Source="ORCID">0000-0002-6901-3681</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Patras Medical School, 26500 Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velissaris</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Patras Medical School, 26500 Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>Ming-Yow</ForeName><Initials>MY</Initials><Identifier Source="ORCID">0000-0002-6912-7523</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Taipei Heart Institute, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mplani</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-1610-0156</Identifier><AffiliationInfo><Affiliation>Intensive Care Unit, Patras University Hospital, 26500 Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saba</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2870-3771</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Azienda Ospedaliero Universitaria di Cagliari, 09045 Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brinia</LastName><ForeName>Aikaterini</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Allergy Practice, King George Square, 26221 Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kouni</LastName><ForeName>Sophia N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Speech Therapy Practice, Queen Olgas Square, 26221 Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gogos</LastName><ForeName>Christos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-9598-6954</Identifier><AffiliationInfo><Affiliation>Covid-19 Unit, Papageorgiou General Hospital, 56403 Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giovannini</LastName><ForeName>Mattia</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9568-6882</Identifier><AffiliationInfo><Affiliation>Allergy Unit, Department of Pediatrics, Meyer Children's University Hospital, 50139 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novembre</LastName><ForeName>Elio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Allergy Unit, Department of Pediatrics, Meyer Children's University Hospital, 50139 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arumugham</LastName><ForeName>Vinu</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cisco Systems, Inc., San Jose, CA 95134, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricke</LastName><ForeName>Darrell O</ForeName><Initials>DO</Initials><AffiliationInfo><Affiliation>Group 49 Biological and Chemical Technologies, Lincoln Laboratory, Massachusetts Institute of Technology, Lexington, MA 02421, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soufras</LastName><ForeName>George D</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Saint Andrews State General Hospital, 26221 Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nugent</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Texas Technical University Health Sciences Center, Lubbock, TX 79430, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sestili</LastName><ForeName>Piero</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9412-1660</Identifier><AffiliationInfo><Affiliation>Department of Biomolecular Sciences, Universita degli Studi di Urbino "Carlo Bo", 61029 Urbino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malone</LastName><ForeName>Robert W</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-0340-7490</Identifier><AffiliationInfo><Affiliation>Vaccines and Biotechnology, Scottsville, VA 24590, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Kounis syndrome</Keyword><Keyword MajorTopicYN="N">anaphylaxis</Keyword><Keyword MajorTopicYN="N">cytokine storm</Keyword><Keyword MajorTopicYN="N">heparin</Keyword><Keyword MajorTopicYN="N">thrombocytopenia</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword></KeywordList><CoiStatement>The authors have no financial or other interest in the product or distributor of the product. Furthermore, they have no other kinds of associations, such as consultancies, stock ownership, or other equity interests or patent-licensing arrangements.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>27</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34440163</ArticleId><ArticleId IdType="pmc">PMC8391920</ArticleId><ArticleId IdType="doi">10.3390/biomedicines9080959</ArticleId><ArticleId IdType="pii">biomedicines9080959</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li Q., Guan X., Wu P., Chu H., To K.K., Yuan S., Yuen K.Y. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N. Engl. J. Med. 2020;382:1199&#x2013;1207. doi: 10.1056/NEJMoa2001316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001316</ArticleId><ArticleId IdType="pmc">PMC7121484</ArticleId><ArticleId IdType="pubmed">31995857</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J.F., Kok K.H., Zhu Z., Chu H., To K.K., Yuan S., Yuen K.Y. Genomic characterization of the 2019 novelhuman-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020;9:221&#x2013;236. doi: 10.1080/22221751.2020.1719902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1719902</ArticleId><ArticleId IdType="pmc">PMC7067204</ArticleId><ArticleId IdType="pubmed">31987001</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen K.G., Rambaut A., Lipkin W.I., Holmes E.C., Garry R.F. The proximal origin of SARS-CoV-2. Nat. Med. 2020;26:450&#x2013;452. doi: 10.1038/s41591-020-0820-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0820-9</ArticleId><ArticleId IdType="pmc">PMC7095063</ArticleId><ArticleId IdType="pubmed">32284615</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia H.P., Look D.C., Shi L., Hickey M., Pewe L., Netland J., Farzan M., Wohlford-Lenane C., Perlman S., McCray P.B., Jr. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J. Virol. 2005;79:14614&#x2013;14621. doi: 10.1128/JVI.79.23.14614-14621.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.23.14614-14621.2005</ArticleId><ArticleId IdType="pmc">PMC1287568</ArticleId><ArticleId IdType="pubmed">16282461</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033&#x2013;1034. doi: 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z., Lian X., Su X., Wu W., Marraro G.A., Zeng Y. From SARS and MERS to COVID-19: A brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir. Res. 2020;21:224. doi: 10.1186/s12931-020-01479-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01479-w</ArticleId><ArticleId IdType="pmc">PMC7450684</ArticleId><ArticleId IdType="pubmed">32854739</ArticleId></ArticleIdList></Reference><Reference><Citation>John Hopkins Coronavirus Resource Center.  [(accessed on 25 June 2020)]; Available online:  https://coronavirus.jhu.edu/data/mortality.</Citation></Reference><Reference><Citation>Abdelrahman Z., Li M., Wang X. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza a Respiratory Viruses. Front. Immunol. 2020;11:552909. doi: 10.3389/fimmu.2020.552909.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.552909</ArticleId><ArticleId IdType="pmc">PMC7516028</ArticleId><ArticleId IdType="pubmed">33013925</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Liu Q., Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol. 2020;92:418&#x2013;423. doi: 10.1002/jmv.25681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25681</ArticleId><ArticleId IdType="pmc">PMC7167049</ArticleId><ArticleId IdType="pubmed">31967327</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Karki C.B., Du D., Teng S., Tang Q., Li L. Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind with Human ACE2. Front. Mol. Biosci. 2020;7:591873. doi: 10.3389/fmolb.2020.591873.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2020.591873</ArticleId><ArticleId IdType="pmc">PMC7755986</ArticleId><ArticleId IdType="pubmed">33363207</ArticleId></ArticleIdList></Reference><Reference><Citation>Peiris J.S., Hui K.P., Yen H.L. Host response to influenza virus: Protectionversus immunopathology. Curr. Opin. Immunol. 2010;22:475&#x2013;481. doi: 10.1016/j.coi.2010.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2010.06.003</ArticleId><ArticleId IdType="pmc">PMC2927395</ArticleId><ArticleId IdType="pubmed">20594815</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisoncik J.R., Korth M.J., Simmons C.P., Farrar J., Martin T.R., Katze M.G. Into the eye of the cytokine storm. Microbiol. Mol. Biol. Rev. 2012;76:16&#x2013;32. doi: 10.1128/MMBR.05015-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.05015-11</ArticleId><ArticleId IdType="pmc">PMC3294426</ArticleId><ArticleId IdType="pubmed">22390970</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D.W., Gardner R., Porter D.L., Louis C.U., Ahmed N., Jensen M., Grupp S.A., Mackall C.L. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124:188&#x2013;195. doi: 10.1182/blood-2014-05-552729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-05-552729</ArticleId><ArticleId IdType="pmc">PMC4093680</ArticleId><ArticleId IdType="pubmed">24876563</ArticleId></ArticleIdList></Reference><Reference><Citation>Suntharalingam G., Perry M.R., Ward S., Brett S.J., Castello-Cortes A., Brunner M.D., Panoskaltsis N. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 2006;355:1018&#x2013;1028. doi: 10.1056/NEJMoa063842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa063842</ArticleId><ArticleId IdType="pubmed">16908486</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroschinsky F., Stolzel F., von Bonin S., Beutel G., Kochanek M., Kiehl M., Schellongowski P. New drugs, new toxicities: Severe side effects of modern targeted and immunotherapy of cancer and their management. Crit. Care. 2017;21:89. doi: 10.1186/s13054-017-1678-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1678-1</ArticleId><ArticleId IdType="pmc">PMC5391608</ArticleId><ArticleId IdType="pubmed">28407743</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu K., Bi Y., Sun K., Wang C. IL-10-producing type 1 regulatory T cells and allergy. Cell Mol. Immunol. 2007;4:269&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pubmed">17764617</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara J.L., Abhyankar S., Gilliland D.G. Cytokine storm of graft versus host disease: A critical effector role for interleukin-1. Transplant. Proc. 1993;25:1216&#x2013;1217.</Citation><ArticleIdList><ArticleId IdType="pubmed">8442093</ArticleId></ArticleIdList></Reference><Reference><Citation>Imashuku S. Clinical features and treatment strategies of Epstein-Barrvirus-associated hemophagocytic lymphohistiocytosis. Crit. Rev. Oncol. Hematol. 2002;44:259&#x2013;272. doi: 10.1016/S1040-8428(02)00117-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1040-8428(02)00117-8</ArticleId><ArticleId IdType="pubmed">12467966</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisno A.L., Brito M.O., Collins C.M. Molecular basis of group Astreptococcal virulence. Lancet Infect. Dis. 2003;3:191&#x2013;200. doi: 10.1016/S1473-3099(03)00576-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(03)00576-0</ArticleId><ArticleId IdType="pubmed">12679262</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokota S. Influenza-associated encephalopathy-pathophysiology and disease mechanisms. Nippon Rinsho. 2003;61:1953&#x2013;1958.</Citation><ArticleIdList><ArticleId IdType="pubmed">14619437</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahrling P.B., Hensley L.E., Martinez M.J., Leduc J.W., Rubins K.H., Relman D.A., Huggins J.W. Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. Proc. Natl. Acad. Sci. USA. 2004;101:15196&#x2013;15200. doi: 10.1073/pnas.0405954101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0405954101</ArticleId><ArticleId IdType="pmc">PMC523454</ArticleId><ArticleId IdType="pubmed">15477589</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K.J., Su I.J., Theron M., Wu Y.C., Lai S.K., Liu C.C., Lei H.Y. An interferon-&#x3b3;-related cytokine storm in SARS patients. J. Med. Virol. 2005;75:185&#x2013;194. doi: 10.1002/jmv.20255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20255</ArticleId><ArticleId IdType="pmc">PMC7166886</ArticleId><ArticleId IdType="pubmed">15602737</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen K.Y., Wong S.S. Human infection by avian influenza A H5N1. Hong Kong Med. J. 2005;11:189&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">15951584</ArticleId></ArticleIdList></Reference><Reference><Citation>Velthuis A.J.W., Long J.C., Bauer D.L.V., Fan R.L.Y., Yen H.L., Sharps J., Siegers J.Y., Killip M.J., French H., Oliva-Mart&#xed;n M.J. Mini viral RNAs act as innate immune agonists during influenza virus infection. Nat. Microbiol. 2018;3:1234&#x2013;1242. doi: 10.1038/s41564-018-0240-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0240-5</ArticleId><ArticleId IdType="pmc">PMC6203953</ArticleId><ArticleId IdType="pubmed">30224800</ArticleId></ArticleIdList></Reference><Reference><Citation>Page D.B., Postow M.A., Callahan M.K., Allison J.P., Wolchok J.D. Immune modulation in cancer with antibodies. Annu. Rev. Med. 2014;65:185&#x2013;202. doi: 10.1146/annurev-med-092012-112807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-092012-112807</ArticleId><ArticleId IdType="pubmed">24188664</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Linden P.W., Hack C.E., Struyvenberg A., Roem D., Brouwer M.C., deBoer J.P., van der Zwan J.K. Controlled insect-sting challenge in 55 patients: Correlation between activation of plasminogen and the development of anaphylactic shock. Blood. 1993;82:1740&#x2013;1748. doi: 10.1182/blood.V82.6.1740.1740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V82.6.1740.1740</ArticleId><ArticleId IdType="pubmed">7691234</ArticleId></ArticleIdList></Reference><Reference><Citation>Castells M. Mast cell mediators in allergic inflammation and mastocytosis. Immunol. Allergy Clin. N. Am. 2006;26:465&#x2013;485. doi: 10.1016/j.iac.2006.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iac.2006.05.005</ArticleId><ArticleId IdType="pubmed">16931289</ArticleId></ArticleIdList></Reference><Reference><Citation>Chousterman B.G., Swirski F.K., Weber G.F. Cytokine storm and sepsis disease pathogenesis. Semin. Immunopathol. 2017;39:517528. doi: 10.1007/s00281-017-0639-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0639-8</ArticleId><ArticleId IdType="pubmed">28555385</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Nie J., Wang H., Zhao Q., Xiong Y., Deng L., Song S., Ma Z., Mo P., Zhang Y. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J. Infect. Dis. 2020;221:1762&#x2013;1769. doi: 10.1093/infdis/jiaa150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa150</ArticleId><ArticleId IdType="pmc">PMC7184346</ArticleId><ArticleId IdType="pubmed">32227123</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q., Wang B., Mao J. The pathogenesis and treatment of the &#x2018;Cytokine Storm&#x2019; in COVID-19. J. Infect. 2020;80:607&#x2013;613. doi: 10.1016/j.jinf.2020.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.037</ArticleId><ArticleId IdType="pmc">PMC7194613</ArticleId><ArticleId IdType="pubmed">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>Comerford I., McColl S.R. Focus on chemokines. Immunol. Cell Biol. 2011;89:183&#x2013;184. doi: 10.1038/icb.2010.164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2010.164</ArticleId><ArticleId IdType="pubmed">21326315</ArticleId></ArticleIdList></Reference><Reference><Citation>Coperchini F., Chiovato L., Croce L., Magri F., Rotondi M. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25&#x2013;32. doi: 10.1016/j.cytogfr.2020.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.05.003</ArticleId><ArticleId IdType="pmc">PMC7211650</ArticleId><ArticleId IdType="pubmed">32446778</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheller J., Rose-John S. Interleukin-6 and its receptor: From bench to bedside. Med. Microbiol. Immunol. 2006;195:173&#x2013;183. doi: 10.1007/s00430-006-0019-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-006-0019-9</ArticleId><ArticleId IdType="pubmed">16741736</ArticleId></ArticleIdList></Reference><Reference><Citation>Brocker C., Thompson D., Matsumoto A., Nebert D.W., Vasiliou V. Evolutionary divergence and functions of the human interleukin (IL) genefamily. Hum. Genom. 2010;5:30&#x2013;55. doi: 10.1186/1479-7364-5-1-30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-7364-5-1-30</ArticleId><ArticleId IdType="pmc">PMC3390169</ArticleId><ArticleId IdType="pubmed">21106488</ArticleId></ArticleIdList></Reference><Reference><Citation>Zemans R.L., Colgan S.P., Downey G.P. Transepithelial migration of neutrophils: Mechanisms and implications for acute lung injury. Am. J. Respir. Cell Mol. Biol. 2009;40:519&#x2013;535. doi: 10.1165/rcmb.2008-0348TR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2008-0348TR</ArticleId><ArticleId IdType="pmc">PMC2677434</ArticleId><ArticleId IdType="pubmed">18978300</ArticleId></ArticleIdList></Reference><Reference><Citation>Neville L.F., Abdullah F., McDonnell P.M., Young P.R., Feuerstein G.Z., Rabinovici R. Mob-1 expression in IL-2-induced ARDS: Regulation by TNFalpha. Pt 1Am. J. Physiol. 1995;269:L884&#x2013;L890. doi: 10.1152/ajplung.1995.269.6.L884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.1995.269.6.L884</ArticleId><ArticleId IdType="pubmed">8572251</ArticleId></ArticleIdList></Reference><Reference><Citation>Borden E.C., Sen G.C., Uze G., Silverman R.H., Ransohoff Foster G.R., Stark G.R. Interferons at age 50: Past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 2007;6:975&#x2013;990. doi: 10.1038/nrd2422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd2422</ArticleId><ArticleId IdType="pmc">PMC7097588</ArticleId><ArticleId IdType="pubmed">18049472</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey S., Bonilla H.F., Jacobson K., Parsonnet J., Andrews J.R., Weiskopf D., Sette A., Pinsky B.A., Singh U., Banaei N. Interferon-gamma release assay for accurate detection of SARS-CoV-2 T cell response. Clin. Infect. Dis. 2020:ciaa1537. doi: 10.1093/cid/ciaa1537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1537</ArticleId><ArticleId IdType="pmc">PMC7665338</ArticleId><ArticleId IdType="pubmed">33035306</ArticleId></ArticleIdList></Reference><Reference><Citation>Carswell E.A., Old L.J., Kassel R.L., Green S., Fiore N., Williamson B. An endotoxin induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA. 1975;72:3666&#x2013;3670. doi: 10.1073/pnas.72.9.3666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.72.9.3666</ArticleId><ArticleId IdType="pmc">PMC433057</ArticleId><ArticleId IdType="pubmed">1103152</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldmann M., Maini R.N., Woody J.N., Holgate S.T., Winter G., Rowland M., Richards D., Hussell T. Trials of anti-tumour necrosis factor therapy forCOVID-19 are urgently needed. Lancet. 2020;39:1407&#x2013;1409. doi: 10.1016/S0140-6736(20)30858-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30858-8</ArticleId><ArticleId IdType="pmc">PMC7158940</ArticleId><ArticleId IdType="pubmed">32278362</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton J.A. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 2008;8:533&#x2013;544. doi: 10.1038/nri2356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2356</ArticleId><ArticleId IdType="pubmed">18551128</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremer P.C., Carey B., Rajendram P., Hudock K.M., Korbee L., Van Tassell B.W., Dagna L., Abbate A. Targeting GM-CSF in COVID-19 Pneumonia:Rationale and Strategies. Front. Immunol. 2020;11:1625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7348297</ArticleId><ArticleId IdType="pubmed">32719685</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimabukuro-Vornhagen A., G&#xf6;del P., Subklewe M., Stemmler H.J., Schl&#xf6;&#xdf;er H.A., Schlaak M., Kochanek M., B&#xf6;ll B., von Bergwelt-Baildon M.S. Cytokine release syndrome. J. Immunother. Cancer. 2018;6:56. doi: 10.1186/s40425-018-0343-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40425-018-0343-9</ArticleId><ArticleId IdType="pmc">PMC6003181</ArticleId><ArticleId IdType="pubmed">29907163</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounis N.G., Soufras G.D., Hahalis G. Anaphylactic cardiac collapse, sudden death and the Kounis syndrome. J. Postgrad. Med. 2014;60:227&#x2013;229. doi: 10.4103/0022-3859.138704.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0022-3859.138704</ArticleId><ArticleId IdType="pubmed">25121360</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay K.A., Hanafi L.-A., Li D., Gust J., Liles W.C., Wurfel M.M., L&#xf3;pez J.A., Chen J., Chung D., Harju-Baker S. Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. Blood. 2017;130:2295&#x2013;2306. doi: 10.1182/blood-2017-06-793141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2017-06-793141</ArticleId><ArticleId IdType="pmc">PMC5701525</ArticleId><ArticleId IdType="pubmed">28924019</ArticleId></ArticleIdList></Reference><Reference><Citation>Neelapu S.S., Tummala S., Kebriaei P., Wierda W., Gutierrez C., Locke F.L., Komanduri K.V., Lin Y., Jain N., Daver N. Chimeric antigen receptor T-cell therapy-assessment and management of toxicities. Nat. Rev. Clin. Oncol. 2018;15:47&#x2013;62. doi: 10.1038/nrclinonc.2017.148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrclinonc.2017.148</ArticleId><ArticleId IdType="pmc">PMC6733403</ArticleId><ArticleId IdType="pubmed">28925994</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Medaglia A.A., Siracusa L., Gio&#xe8; C., Giordano S., Cascio A., Colomba C. Kawasaki disease recurrence in the COVID-19 era: A systematic review of the literature. Ital. J. Pediatr. 2021;47:95. doi: 10.1186/s13052-021-01041-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-021-01041-4</ArticleId><ArticleId IdType="pmc">PMC8054252</ArticleId><ArticleId IdType="pubmed">33874991</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowley A.H., Baker S.C., Arrollo D., Gruen L.J., Bodnar T., Innocentini N., Hackbart M., Cruz-Pulido Y.E., Wylie K.M., Kim K.A., et al. A Protein Epitope Targeted by the Antibody Response to Kawasaki Disease. J. Infect. Dis. 2020;222:158&#x2013;168. doi: 10.1093/infdis/jiaa066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa066</ArticleId><ArticleId IdType="pmc">PMC7296860</ArticleId><ArticleId IdType="pubmed">32052021</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowley A.H. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children. Nat. Rev. Immunol. 2020;20:453&#x2013;454. doi: 10.1038/s41577-020-0367-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0367-5</ArticleId><ArticleId IdType="pmc">PMC7296515</ArticleId><ArticleId IdType="pubmed">32546853</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris S.B., Schwartz N.G., Patel P., Abbo L., Beauchamps L., Balan S., Lee E.H., Paneth-Pollak R., Geevarughese A., Lash M.K., et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection&#x2014;United Kingdom and United States, March-August 2020. MMWR Morb. Mortal. Wkl. Rep. 2020;69:1450&#x2013;1456. doi: 10.15585/mmwr.mm6940e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6940e1</ArticleId><ArticleId IdType="pmc">PMC7561225</ArticleId><ArticleId IdType="pubmed">33031361</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio C.R., Cotugno N., Sardh F., Pou C., Amodio D., Rodriguez L., Tan Z., Zicari S., Ruggiero A., Pascucci G.R., et al. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell. 2020;183:968&#x2013;981.e7. doi: 10.1016/j.cell.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber C.N., Patel R.S., Trachtman R., Lepow L., Amanat F., Krammer F., Wilson K.M., Onel K., Geanon D., Tuballes K., et al. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C) Cell. 2020;183:982&#x2013;995.e14. doi: 10.1016/j.cell.2020.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.034</ArticleId><ArticleId IdType="pmc">PMC7489877</ArticleId><ArticleId IdType="pubmed">32991843</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakoub-Agha I., Chabannon C., Bader P., Basak G.W., Bonig H., Ciceri F., Corbacioglu S., Duarte R.F., Einsele H., Hudecek M., et al. Management of adults and children undergoing chimeric antigen receptor T-cell therapy: Best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) Haematologica. 2020;105:297&#x2013;316. doi: 10.3324/haematol.2019.229781.</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2019.229781</ArticleId><ArticleId IdType="pmc">PMC7012497</ArticleId><ArticleId IdType="pubmed">31753925</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Wu Z., Li J.W., Zhao H., Wang G.Q. Cytokine release syndrome in severe COVID-19: Interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int. J. Antimicrob. Agents. 2020;55:105954. doi: 10.1016/j.ijantimicag.2020.105954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105954</ArticleId><ArticleId IdType="pmc">PMC7118634</ArticleId><ArticleId IdType="pubmed">32234467</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Tan Su Yin E., Yang Y., Wu H., Wei G., Su J., Cui Q., Jin A., Yang L., Fu S., et al. CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challenges. Curr. Res. Transl. Med. 2020;68:111&#x2013;118. doi: 10.1016/j.retram.2020.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.retram.2020.06.003</ArticleId><ArticleId IdType="pmc">PMC7321051</ArticleId><ArticleId IdType="pubmed">32620465</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum D.C., June C.H. Cytokine Storm. N. Engl. J. Med. 2020;383:2255&#x2013;2273. doi: 10.1056/NEJMra2026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J., Liu Y., Wang C., Zhang Y., Tong C., Dai G., Wang W., Rasko J.E.J., Melenhorst J.J., Qian W., et al. The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma. Signal Transduct, Target. Ther. 2020;5:134. doi: 10.1038/s41392-020-00256-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00256-x</ArticleId><ArticleId IdType="pmc">PMC7388484</ArticleId><ArticleId IdType="pubmed">32728035</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliynyk O., Barg W., Slifirczyk A., Oliynyk Y., Gurianov V., Rorat M. Efficacy of Tocilizumab Therapy in Different Subtypes of COVID-19 Cytokine Storm Syndrome. Viruses. 2021;13:1067. doi: 10.3390/v13061067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13061067</ArticleId><ArticleId IdType="pmc">PMC8229480</ArticleId><ArticleId IdType="pubmed">34205217</ArticleId></ArticleIdList></Reference><Reference><Citation>Yongzhi X. COVID-19-associated cytokine storm syndrome and diagnostic principles: An old and new Issue. Emerg. Microbes Infect. 2021;10:266&#x2013;276. doi: 10.1080/22221751.2021.1884503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1884503</ArticleId><ArticleId IdType="pmc">PMC7894425</ArticleId><ArticleId IdType="pubmed">33522893</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounis N.G., Mazarakis A., Tsigkas G., Giannopoulos S., Goudevenos J. Kounis syndrome: A new twist on an old disease. Future Cardiol. 2011;7:805&#x2013;824. doi: 10.2217/fca.11.63.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fca.11.63</ArticleId><ArticleId IdType="pubmed">22050066</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone S.F., Cotterell C., Isbister G.K., Holdgate A., Brown S.G., Emergency Department Anaphylaxis Investigators Elevated serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactions. J. Allergy Clin. Immunol. 2009;124:786&#x2013;792.e4. doi: 10.1016/j.jaci.2009.07.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2009.07.055</ArticleId><ArticleId IdType="pubmed">19767073</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa Y., Grant J.A. Mediators of anaphylaxis. Immunol. Allergy Clin. N. Am. 2007;27:249&#x2013;260. doi: 10.1016/j.iac.2007.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iac.2007.03.013</ArticleId><ArticleId IdType="pubmed">17493501</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari H., Chan-Yeung M. Mast cell mediators stimulate synthesis of arachidonic acid metabolites in macrophages. J. Immunol. 1989;142:2821&#x2013;2827.</Citation><ArticleIdList><ArticleId IdType="pubmed">2495326</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambayashi T., Allenspach E.J., Chang J.T., Zou T., Shoag J.E., Reiner S.L., Caton A.J., Koretzky G.A. Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation. J. Immunol. 2009;182:4686&#x2013;4695. doi: 10.4049/jimmunol.0803180.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0803180</ArticleId><ArticleId IdType="pmc">PMC2922395</ArticleId><ArticleId IdType="pubmed">19342644</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki D., Nakamura T., Toda M., Cheung-Chau K.W., Richardson R.M., Ono S.J. Macrophage inflammatory protein-1a as a costimulatory signal for mast cell mediated immediate hypersensitivity reactions. J. Clin. Investig. 2005;115:434&#x2013;442. doi: 10.1172/JCI18452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI18452</ArticleId><ArticleId IdType="pmc">PMC544033</ArticleId><ArticleId IdType="pubmed">15650768</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Pomares L., Gordon S. CD169_macrophages at the crossroads of antigen presentation. Trends Immunol. 2012;33:66&#x2013;70. doi: 10.1016/j.it.2011.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2011.11.001</ArticleId><ArticleId IdType="pubmed">22192781</ArticleId></ArticleIdList></Reference><Reference><Citation>Mekori Y.A., Metcalfe D.D. Mast cell-T cell interactions. J. Allergy Clin. Immunol. 1999;104:517&#x2013;523. doi: 10.1016/S0091-6749(99)70316-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0091-6749(99)70316-7</ArticleId><ArticleId IdType="pubmed">10482820</ArticleId></ArticleIdList></Reference><Reference><Citation>Doherty T.M. T cell regulation of macrophage function. Curr. Opin. Immunol. 1995;7:400&#x2013;404. doi: 10.1016/0952-7915(95)80117-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0952-7915(95)80117-0</ArticleId><ArticleId IdType="pubmed">7546407</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahinden C.A., Geiser T., Brunner T., von Tscharner V., Caput D., Ferrara P., Minty A., Baggiolini M. Monocyte chemotactic protein 3 is a most effective basophil-and eosinophil-activating chemokine. J. Exp. Med. 1994;179:751&#x2013;756. doi: 10.1084/jem.179.2.751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.179.2.751</ArticleId><ArticleId IdType="pmc">PMC2191381</ArticleId><ArticleId IdType="pubmed">7507512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferenbach D., Hughes J. Macrophages and dendritic cells: What is the difference? Kidney Int. 2008;74:5&#x2013;7. doi: 10.1038/ki.2008.189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2008.189</ArticleId><ArticleId IdType="pubmed">18560360</ArticleId></ArticleIdList></Reference><Reference><Citation>Dollery C.M., Libby P. Atherosclerosis and proteinase activation. Cardiovasc. Res. 2006;69:625&#x2013;635. doi: 10.1016/j.cardiores.2005.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardiores.2005.11.003</ArticleId><ArticleId IdType="pubmed">16376322</ArticleId></ArticleIdList></Reference><Reference><Citation>Newby A.C. Metalloproteinases promote plaque rupture and myocardial infarction: A persuasive concept waiting for clinical translation. Matrix Biol. 2015;44&#x2013;46:157&#x2013;166. doi: 10.1016/j.matbio.2015.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2015.01.015</ArticleId><ArticleId IdType="pubmed">25636537</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham A.C., Temple R.M., Obar J.J. Mast cells and influenza a virus: Association with allergic responses and beyond. Front. Immunol. 2015;6:238. doi: 10.3389/fimmu.2015.00238.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00238</ArticleId><ArticleId IdType="pmc">PMC4435071</ArticleId><ArticleId IdType="pubmed">26042121</ArticleId></ArticleIdList></Reference><Reference><Citation>Galli S.J., Tsai M. Mast cells in allergy and infection: Versatile effector and regulatory cells in innate and adaptive immunity. Eur. J. Immunol. 2010;40:1843&#x2013;1851. doi: 10.1002/eji.201040559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201040559</ArticleId><ArticleId IdType="pmc">PMC3581154</ArticleId><ArticleId IdType="pubmed">20583030</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann A.M., Abraham S.N. New roles for mast cells in modulating allergic reactions and immunity against pathogens. Curr. Opin. Immunol. 2009;21:679&#x2013;686. doi: 10.1016/j.coi.2009.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2009.09.007</ArticleId><ArticleId IdType="pmc">PMC2787974</ArticleId><ArticleId IdType="pubmed">19828301</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawicki W., Marshall J.S. New and emerging roles for mast cells in host defence. Curr. Opin. Immunol. 2007;19:31&#x2013;38. doi: 10.1016/j.coi.2006.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2006.11.006</ArticleId><ArticleId IdType="pubmed">17126541</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundstrom J.B., Hair G.A., Ansari A.A., Secor W.E., Gilfillan A.M., Metcalfe D.D., Kirshenbaum A.S. I gE-Fcepsilon RI interaction determine HIV co-receptor usage and susceptibility to infection during ontogeny of mast cells. J. Immunol. 2009;182:6401&#x2013;6409. doi: 10.4049/jimmunol.0801481.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0801481</ArticleId><ArticleId IdType="pmc">PMC2791323</ArticleId><ArticleId IdType="pubmed">19414793</ArticleId></ArticleIdList></Reference><Reference><Citation>Orinska Z., Bulanova E., Budagian V., Metz M., Maurer M., Bulfone-Paus S. TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood. 2005;106:978&#x2013;987. doi: 10.1182/blood-2004-07-2656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2004-07-2656</ArticleId><ArticleId IdType="pubmed">15840693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulka M., Alexopoulou L., Flavell R.A., Metcalfe D.D. Activation of mast cellsby double-stranded RNA: Evidence for activation through Toll-like receptor 3. J. Allergy Clin. Immunol. 2004;114:174&#x2013;182. doi: 10.1016/j.jaci.2004.03.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2004.03.049</ArticleId><ArticleId IdType="pubmed">15241362</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounis N.G. Coronary hypersensitivity disorder: The Kounis syndrome. Clin. Ther. 2013;35:563&#x2013;571. doi: 10.1016/j.clinthera.2013.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2013.02.022</ArticleId><ArticleId IdType="pubmed">23490289</ArticleId></ArticleIdList></Reference><Reference><Citation>Joob B., Wiwanitkit V. Hemorrhagic Problem among the Patients with COVID-19: Clinical Summary of 41 Thai Infected Patients. Clin. Appl. Thromb. Hemost. 2020;26:1076029620918308. doi: 10.1177/1076029620918308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029620918308</ArticleId><ArticleId IdType="pmc">PMC7289062</ArticleId><ArticleId IdType="pubmed">32250159</ArticleId></ArticleIdList></Reference><Reference><Citation>Malavige G.N., Ogg G.S. Pathogenesis of vascular leak in dengue virus infection. Immunology. 2017;151:261&#x2013;269. doi: 10.1111/imm.12748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12748</ArticleId><ArticleId IdType="pmc">PMC5461104</ArticleId><ArticleId IdType="pubmed">28437586</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman-Rodriguez M., Acosta-Nanez H.F., Mantilla J.C., Bonelo A. Dengue Virus and Influenza A Virus Co-Infection in Pregnancy: A Case Report. Trop. Med. Infect. Dis. 2019;4:84. doi: 10.3390/tropicalmed4020084.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed4020084</ArticleId><ArticleId IdType="pmc">PMC6631397</ArticleId><ArticleId IdType="pubmed">31117316</ArticleId></ArticleIdList></Reference><Reference><Citation>Marone G., Florio G., Petraroli A., Triggiani M., de Paulis A. Role of human FcepsilonRI+ cells in HIV-1 infection. Immunol. Rev. 2001;179:128&#x2013;138. doi: 10.1034/j.1600-065X.2001.790113.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-065X.2001.790113.x</ArticleId><ArticleId IdType="pubmed">11292016</ArticleId></ArticleIdList></Reference><Reference><Citation>Westendorp M.O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K.M., Krammer P.H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature. 1995;37:497&#x2013;500. doi: 10.1038/375497a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/375497a0</ArticleId><ArticleId IdType="pubmed">7539892</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounis N.G., Zavras G.M. Histamine-induced coronary artery spasm: The concept of allergic angina. Br. J. Clin. Pract. 1991;45:121&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">1793697</ArticleId></ArticleIdList></Reference><Reference><Citation>Rich M.W. Is vasospastic angina an inflammatory disease? Am. J. Cardiol. 2005;96:1612. doi: 10.1016/j.amjcard.2005.02.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2005.02.061</ArticleId><ArticleId IdType="pubmed">16310451</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounis N.G., Kourelis T., Hahalis G., Manola A., Theoharides T.C. Kounis syndrome (allergic angina and allergic myocardial infarction) In: Gallo A.P., editor. Angina Pectoris. Nova Biomedical Books; New York, NY, USA: 2008. pp. 6&#x2013;150.</Citation></Reference><Reference><Citation>Hasegawa S., Tashiro N., Matsubara T., Furukawa S., Ra C. A comparison of FcepsilonRI-mediated RANTES release from human platelets between allergic patients and healthy individuals. Int. Arch. Allergy Immunol. 2001;125(Suppl. S1):42&#x2013;47. doi: 10.1159/000053852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000053852</ArticleId><ArticleId IdType="pubmed">11408772</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounis N.G., Koniari I., Velissaris D., Tzanis G., Hahalis G. Kounis Syndrome&#x2014;Not a Single-organ Arterial Disorder but a Multisystem and Multidisciplinary Disease. Balkan Med. J. 2019;36:212&#x2013;221. doi: 10.4274/balkanmedj.galenos.2019.2019.5.62.</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/balkanmedj.galenos.2019.2019.5.62</ArticleId><ArticleId IdType="pmc">PMC6636655</ArticleId><ArticleId IdType="pubmed">31198019</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi G., Pellegrini C., Maurelli M., Belliato M., Sciutti F., Bottazzi A., Sepe P.A., Resasco T., Camporotondo R., Bruno R., et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur. J. Heart Fail. 2020;22:911&#x2013;915. doi: 10.1002/ejhf.1828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1828</ArticleId><ArticleId IdType="pmc">PMC7262276</ArticleId><ArticleId IdType="pubmed">32275347</ArticleId></ArticleIdList></Reference><Reference><Citation>Prieto-Lobato A., Ramos-Mart&#xed;nez R., Vallejo-Calcerrada N., Corb&#xed;-Pascual M., C&#xf3;rdoba-Soriano J.G. A Case Series of Stent Thrombosis during the COVID-19 Pandemic. JACC Case Rep. 2020;2:1291&#x2013;1296. doi: 10.1016/j.jaccas.2020.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2020.05.024</ArticleId><ArticleId IdType="pmc">PMC7255188</ArticleId><ArticleId IdType="pubmed">32835270</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez-Erquicia P., Dobarro D., Raposeiras-Roubin S., Bastos-Fernandez G., Iniguez-Romo A. Multivessel coronary thrombosis in a patient with COVID-19 pneumonia. Eur. Heart J. 2020;41:2132. doi: 10.1093/eurheartj/ehaa393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa393</ArticleId><ArticleId IdType="pmc">PMC7239221</ArticleId><ArticleId IdType="pubmed">32374373</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounis N.G., Koniari I., Tsigkas G., Davlouros P. Humanized Monoclonal Antibodies Against IgE Antibodies as Therapy for IgE-Mediated Coronary Syndromes: Are We There Yet? Can. J. Cardiol. 2020;36:816&#x2013;819. doi: 10.1016/j.cjca.2020.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2020.01.008</ArticleId><ArticleId IdType="pubmed">32536372</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C., Wong P., Klein J., Castro T.B.R., Silva J., Sundaram M., Ellingson M.K., Mao T., Oh J.E., Israelow B., et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584:463&#x2013;469. doi: 10.1038/s41586-020-2588-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertekin A. Triggered by Covid-19? Large Vascular Occlusion Resulting in Cytokine Storm Syndrome and Kounis Syndrome: A Case Report. J. Biomed. Res. Environ. Sci. 2021;2:030&#x2013;033.</Citation></Reference><Reference><Citation>Wang M., Talon A., Saririan M. COVID-19 cardiac arrest due to Prinzmetal&#x2019;s angina in a previously normal heart. Clin. Case Rep. 2021;9:e04205. doi: 10.1002/ccr3.4205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.4205</ArticleId><ArticleId IdType="pmc">PMC8223695</ArticleId><ArticleId IdType="pubmed">34194776</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajstra M., Jaroszewicz J., G&#x105;sior M. Acute Coronary Tree Thrombosis after Vaccination for COVID-19. JACC Cardiovasc. Interv. 2021;14:e103&#x2013;e104. doi: 10.1016/j.jcin.2021.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2021.03.003</ArticleId><ArticleId IdType="pmc">PMC8092130</ArticleId><ArticleId IdType="pubmed">33958175</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zdemir &#x130;.H., &#xd6;zlek B., &#xd6;zen M.B., G&#xfc;nd&#xfc;z R., Bayturan &#xd6;. Type 1 Kounis Syndrome Induced by Inactivated SARS-COV-2 Vaccine. J. Emerg. Med. 2021 doi: 10.1016/j.jemermed.2021.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2021.04.018</ArticleId><ArticleId IdType="pmc">PMC8103145</ArticleId><ArticleId IdType="pubmed">34148772</ArticleId></ArticleIdList></Reference><Reference><Citation>Riegger J., Byrne R.A., Joner M., Chandraratne S., Gershlick A.H., Ten Berg J.M., Adriaenssens T., Guagliumi G., Godschalk T.C., Neumann F.J. Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: A report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium. Eur. Heart J. 2016;37:1538&#x2013;1549. doi: 10.1093/eurheartj/ehv419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv419</ArticleId><ArticleId IdType="pmc">PMC4872283</ArticleId><ArticleId IdType="pubmed">26761950</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedberg D.E., Conigliaro J., Wang T.C., Tracey K.J., Callahan M.V., Abrams J.A. Famotidine Use Is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study. Gastroenterology. 2020;159:1129&#x2013;1131.e3. doi: 10.1053/j.gastro.2020.05.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.053</ArticleId><ArticleId IdType="pmc">PMC7242191</ArticleId><ArticleId IdType="pubmed">32446698</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.P., Hou D., Pendyala L., Goudevenos J.A., Kounis N.G. Drug eluting stent thrombosis: The Kounis hypersensitivity-associated acute coronary syndrome revisited. J. Am. Coll. Cardiol. Intv. 2009;2:583&#x2013;593. doi: 10.1016/j.jcin.2009.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2009.04.017</ArticleId><ArticleId IdType="pubmed">19628178</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo T., Chen B., Zhao Z., He N., Zeng Z., Wu B., Fukushima Y., Dai M., Huang Q., Xu D. Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function. Basic Res. Cardiol. 2013;108:342. doi: 10.1007/s00395-013-0342-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-013-0342-4</ArticleId><ArticleId IdType="pubmed">23467745</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group. Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L., Linsell L., Staplin N., Brightling C., Ustianowski A., et al. Dexamethasone in Hospitalized Patients with Covid-19. N. Engl. J. Med. 2021;384:693&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Lu C., Guo Q. Recurrent Type III Kounis Syndrome: Will Anti-Immunoglobulin E Drug Be Another Option? Can. J. Cardiol. 2020;36:e5&#x2013;e966. doi: 10.1016/j.cjca.2019.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2019.12.007</ArticleId><ArticleId IdType="pubmed">32536377</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E.J., Cines D.B., Gernsheimer T., Kessler C., Michel M., Tarantino M.D., Semple J.W., Arnold D.M., Godeau B., Lambert M.P., et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am. J. Hematol. 2021;96:534&#x2013;537. doi: 10.1002/ajh.26132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26132</ArticleId><ArticleId IdType="pmc">PMC8014568</ArticleId><ArticleId IdType="pubmed">33606296</ArticleId></ArticleIdList></Reference><Reference><Citation>Cines D.B., Bussel J.B. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. N. Engl. J. Med. 2021;384:2254&#x2013;2256. doi: 10.1056/NEJMe2106315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2106315</ArticleId><ArticleId IdType="pmc">PMC8063912</ArticleId><ArticleId IdType="pubmed">33861524</ArticleId></ArticleIdList></Reference><Reference><Citation>Karron R.A., Key N.S., Sharfstein J.M. Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine. JAMA. 2021;325:2445&#x2013;2447. doi: 10.1001/jama.2021.7637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.7637</ArticleId><ArticleId IdType="pubmed">33929484</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuder M.M., Lang D.M., Patadia D.D. Anaphylaxis to vaccinations: A review of the literature and evaluation of the COVID-19 mRNA vaccinations. Cleve Clin. J. Med. 2021 doi: 10.3949/ccjm.88a.ccc075. Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.88a.ccc075</ArticleId><ArticleId IdType="pubmed">33648932</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeil M.M., DeStefano F. Vaccine-associated hypersensitivity. J. Allergy Clin. Immunol. 2018;141:463&#x2013;472. doi: 10.1016/j.jaci.2017.12.971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.12.971</ArticleId><ArticleId IdType="pmc">PMC6602527</ArticleId><ArticleId IdType="pubmed">29413255</ArticleId></ArticleIdList></Reference><Reference><Citation>Pf&#xf6;hler C., M&#xfc;ller C.S., Pindur G., Eichler H., Sch&#xe4;fers H.J., Grundmann U., Tilgen W. Delayed-type heparin allergy: Diagnostic procedures and treatment alternatives-a case series including 15 patients. World Allergy Organ. J. 2008;1:194&#x2013;199. doi: 10.1097/WOX.0b013e31818def58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WOX.0b013e31818def58</ArticleId><ArticleId IdType="pmc">PMC3650972</ArticleId><ArticleId IdType="pubmed">23282847</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J., Madeeva D., Hayes V., Ahn H.S., Tutwiler V., Arepally G.M., Cines D.B., Poncz M., Rauova L. Dynamic intercellular redistribution of HIT antigen modulates heparin-induced thrombocytopenia. Blood. 2018;132:727&#x2013;773. doi: 10.1182/blood-2018-02-830737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-02-830737</ArticleId><ArticleId IdType="pmc">PMC6097133</ArticleId><ArticleId IdType="pubmed">29914979</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangalore S., Sharma A., Slotwiner A., Yatskar L., Harari R., Shah B., Ibrahim H., Friedman G.H., Thompson C., Alviar C.L., et al. ST-Segment Elevation in Patients with Covid-19&#x2014;A Case Series. N. Engl. J. Med. 2020;382:2478&#x2013;2480. doi: 10.1056/NEJMc2009020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009020</ArticleId><ArticleId IdType="pmc">PMC7182015</ArticleId><ArticleId IdType="pubmed">32302081</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong B.H. Heparin-induced thrombocytopenia. Br. J. Haematol. 1995;89:431&#x2013;439. doi: 10.1111/j.1365-2141.1995.tb08346.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.1995.tb08346.x</ArticleId><ArticleId IdType="pubmed">7734342</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounis N.G., Soufras G.D., Almpanis G., Tsigkas G., Mazarakis A. Acute stent thrombosis and heparin induced thrombocytopenia: Another manifestation of kounis syndrome? Korean Circ. J. 2013;43:221&#x2013;222. doi: 10.4070/kcj.2013.43.4.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.4070/kcj.2013.43.4.221</ArticleId><ArticleId IdType="pmc">PMC3654108</ArticleId><ArticleId IdType="pubmed">23682280</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P.R., ApapMangion S., Benger M., Stanton B.R., Czuprynska J., Arya R., Sztriha L.K. Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination&#x2014;A report of two UK cases. Brain Behav. Immun. 2021;95:514&#x2013;517. doi: 10.1016/j.bbi.2021.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.04.006</ArticleId><ArticleId IdType="pmc">PMC8056834</ArticleId><ArticleId IdType="pubmed">33857630</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounis N.G., Koniari I., de Gregorio C. COVID-19 and Kounis Syndrome: Deciphering Their Relationship. Balkan Med. J. 2021;38:145&#x2013;149. doi: 10.5152/balkanmedj.2021.21097.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/balkanmedj.2021.21097</ArticleId><ArticleId IdType="pubmed">34142957</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounis N.G., Soufras G.D., Lianas D., Patsouras N. Heparin-induced thrombocytopenia, allergy to heparins, heart failure, thrombi, and the Kounis syndrome. Int. J. Cardiol. 2016;214:508&#x2013;509. doi: 10.1016/j.ijcard.2016.02.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.02.110</ArticleId><ArticleId IdType="pubmed">26924159</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounis N.G., Koniari I., Soufras G.D., Tsigkas G., Plotas P., Davlouros P., Hahalis G. The paradox of heparin induced thrombocytopenia-thrombosis, the role of fondaparinux and the need for new therapeutic strategies. Int. Angiol. 2020;39:350&#x2013;351. doi: 10.23736/S0392-9590.20.04364-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0392-9590.20.04364-3</ArticleId><ArticleId IdType="pubmed">32214073</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartzberg L.S., Navari R.M. Safety of polysorbate 80 in the oncology setting. Adv. Ther. 2018;35:754&#x2013;767. doi: 10.1007/s12325-018-0707-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-018-0707-z</ArticleId><ArticleId IdType="pmc">PMC6015121</ArticleId><ArticleId IdType="pubmed">29796927</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L.X., Liu A.C., Yu S.W., Wang Z.X., Lin X.Q., Zhai G.X., Zhang Q.Z. The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury. Biol. Pharm. Bull. 2013;36:1263&#x2013;1270. doi: 10.1248/bpb.b12-00769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.b12-00769</ArticleId><ArticleId IdType="pubmed">23902970</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyapina M.G., Stoyanova Dencheva M. Contact sensitization to ingredients of dental materials and cosmetics in dental students: A pilot study. Cent. Eur. J. Public Health. 2019;27:73&#x2013;77. doi: 10.21101/cejph.a4756.</Citation><ArticleIdList><ArticleId IdType="doi">10.21101/cejph.a4756</ArticleId><ArticleId IdType="pubmed">30927402</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukawska J., Mandaliya D., Chan A.W.E., Foggitt A., Bidder T., Harvey J., Stycharczuk L., Bisdas S. Anaphylaxis to trometamol excipient in gadolinium-based contrast agents for clinical imaging. J. Allergy Clin. Immunol. Pract. 2019;7:1086&#x2013;1087. doi: 10.1016/j.jaip.2018.08.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2018.08.035</ArticleId><ArticleId IdType="pubmed">30217530</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggio E.T. Alkylsaccharides: Circumventing oxidative damage to biotherapeutics caused by polyoxyethylene-based surfactants. Ther. Deliv. 2013;4:567&#x2013;572. doi: 10.4155/tde.13.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/tde.13.19</ArticleId><ArticleId IdType="pubmed">23647275</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell L.A., Rosenfeld M.E. Infection and Atherosclerosis Development. Arch Med. Res. 2015;46:339&#x2013;350. doi: 10.1016/j.arcmed.2015.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2015.05.006</ArticleId><ArticleId IdType="pmc">PMC4524506</ArticleId><ArticleId IdType="pubmed">26004263</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D., O&#x2019;Donnell J.S., Sharif K., Emery P., Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020;2:e437&#x2013;e445. doi: 10.1016/S2665-9913(20)30121-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30121-1</ArticleId><ArticleId IdType="pmc">PMC7252093</ArticleId><ArticleId IdType="pubmed">32835247</ArticleId></ArticleIdList></Reference><Reference><Citation>Saba L., Gerosa C., Wintermark M., Hedin U., Fanni D., Suri J.S., Faa G. Can COVID 19 trigger the plaque vulnerability&#x2014;A Kounis syndrome warning for &#x201c;asymptomatic subjects&#x201d;. Cardiovasc. Diagn. Ther. 2020 doi: 10.21037/cdt-20-561.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/cdt-20-561</ArticleId><ArticleId IdType="pmc">PMC7666923</ArticleId><ArticleId IdType="pubmed">33224760</ArticleId></ArticleIdList></Reference><Reference><Citation>Kritas S.K., Ronconi G., Caraffa A., Gallenga C.E., Ross R., Conti P. Mast cells contribute to coronavirus-induced inflammation: New anti-inflammatory strategy. J. Biol. Regul. Homeost. Agents. 2020;34:9&#x2013;14. doi: 10.23812/20-Editorial-Kritas.</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/20-Editorial-Kritas</ArticleId><ArticleId IdType="pubmed">32013309</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilie P.C., Stefanescu S., Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin. Exp Res. 2020;32:1195&#x2013;1198. doi: 10.1007/s40520-020-01570-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01570-8</ArticleId><ArticleId IdType="pmc">PMC7202265</ArticleId><ArticleId IdType="pubmed">32377965</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanini G.G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M., Metra M., Curello S., Maffeo D., Pero G. ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes. Circulation. 2020;141:2113&#x2013;2116. doi: 10.1161/CIRCULATIONAHA.120.047525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047525</ArticleId><ArticleId IdType="pmc">PMC7302062</ArticleId><ArticleId IdType="pubmed">32352306</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounis N.G., Koniari I., Soufras G.D., Chourdakis E., Despotopoulos S., Davlouros P., Hahalis G. Respiratory Infections as Predictors of Hospital Admission for Myocardial Infarction and Stroke: Pathophysiologic and Therapeutic Considerations. Clin. Infect. Dis. 2019;68:533. doi: 10.1093/cid/ciy685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy685</ArticleId><ArticleId IdType="pubmed">30304438</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackburn R.M., Zhao H., Pebody R., Hayward A.C., Warren-Gash C. Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: Time-series analysis of English data for 2004&#x2013;2015. Clin. Infect. Dis. 2018;67:8&#x2013;17. doi: 10.1093/cid/cix1144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix1144</ArticleId><ArticleId IdType="pmc">PMC6005111</ArticleId><ArticleId IdType="pubmed">29324996</ArticleId></ArticleIdList></Reference><Reference><Citation>Onozuka D., Hagihara A. Extreme influenza epidemics and out-of-hospital cardiac arrest. Int. J. Cardiol. 2018;263:158&#x2013;162. doi: 10.1016/j.ijcard.2018.02.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2018.02.028</ArticleId><ArticleId IdType="pubmed">29754914</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei J., Kusov Y., Hilgenfeld R. Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein. Antiviral. Res. 2018;149:58&#x2013;74. doi: 10.1016/j.antiviral.2017.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.11.001</ArticleId><ArticleId IdType="pmc">PMC7113668</ArticleId><ArticleId IdType="pubmed">29128390</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane H.C., Fauci A.S. Research in the Context of a Pandemic. N. Engl. J. Med. 2021;384:755&#x2013;757. doi: 10.1056/NEJMe2024638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2024638</ArticleId><ArticleId IdType="pmc">PMC7383591</ArticleId><ArticleId IdType="pubmed">32678528</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha J.F. The COVID-19 pandemic, personal protective equipment and respirator: A narrative review. Int. J. Clin. Pract. 2020;74:e13578. doi: 10.1111/ijcp.13578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13578</ArticleId><ArticleId IdType="pmc">PMC7300506</ArticleId><ArticleId IdType="pubmed">32511834</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M.A., Lee Y.W., Kim S.R., Kim J.H., Min T.K., Park H.S., Shin M., Ye Y.M., Lee S., Lee J., et al. COVID-19 Vaccine-associated Anaphylaxis and Allergic Reactions: Consensus Statements of the KAAACI Urticaria/Angioedema/Anaphylaxis Working Group. Allergy Asthma Immunol. Res. 2021;13:526&#x2013;544. doi: 10.4168/aair.2021.13.4.526.</Citation><ArticleIdList><ArticleId IdType="doi">10.4168/aair.2021.13.4.526</ArticleId><ArticleId IdType="pmc">PMC8255352</ArticleId><ArticleId IdType="pubmed">34212542</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounis N.G., Koniari I., de Gregorio C., Velissaris D., Petalas K., Brinia A., Assimakopoulos S.F., Gogos C., Kouni S.N., Kounis G.N., et al. Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations. Vaccines. 2021;9:221. doi: 10.3390/vaccines9030221.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9030221</ArticleId><ArticleId IdType="pmc">PMC7999280</ArticleId><ArticleId IdType="pubmed">33807579</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>